Save up -80% on Omacetaxine mepesuccinate

Note: this is a drug discount program, not an insurance plan.
RX BIN: 015558RX PCN: HTGroup ID: DDN6600Card Holder ID: DDN6600
Pharmacists and Patients support.

2019 Price of Synribo

$8,2581 vial (8ml) 3.5mg
price without discount in nearest pharmacy. Price may vary.

Claim your free Omacetaxine mepesuccinate discount card

We offer free Omacetaxine mepesuccinate coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Omacetaxine mepesuccinate every time. What are you waiting for? Claim your prescription drug card now!

Walgreens pharmacy
Walgreens pharmacy
CVS pharmacy
CVS pharmacy
Walmart pharmacy
Walmart pharmacy
Ride AID pharmacy
Ride AID pharmacy
CVS Target pharmacy
CVS Target pharmacy
Kroger pharmacy
Kroger pharmacy
rx

Get your Prescription

safe

It’s safe and free

pharmacy

Buy drugs in pharmacy

save money

Save money each time

Omacetaxine mepesuccinate volume of distribution

Homoharringtonine has a steady state Vd of 141 93.4 L.

RX Prescription
Ask Your therapeut before taking any drugs.

About RX24Drugs

2018 Statistics

discount card

Discount Cards 16,000+

benefit

Clients Benefit 29%

savings

Total savings $4,735,080

What is Omacetaxine mepesuccinate

Omacetaxine mepesuccinate (formerly known as HHT or Homoharringtonine), is a cephalotaxine ester and protein synthesis inhibitor with established clinical activity as a single agent in hematological malignancies. Omacetaxine mepesuccinate is synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. In October 2005, omacetaxine mepesuccinate received Orphan Drug designation from the EMEA for the treatment of chronic myeloid leukemia (CML). Then in March 2006, it received Orphan Drug status from the FDA for the treatment of CML. In November 2006, omacetaxine mepesuccinate, for the treatment of CML, was granted Fast Track designation by the FDA. Most recently, in October 2012, omacetaxine mepesuccinate was marketed under the brand name Synribo and FDA approved for patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.

Omacetaxine mepesuccinate mechanism of action

Homoharringtonine inhibits protein synthesis by not directly binding to Bcr-Abl. It binds to the A-site cleft in the large ribosomal subunit, which affects chain elongation and prevents protein synthesis.

Dosage forms of Omacetaxine mepesuccinate

FormRouteStrength
Injection, powder, lyophilized, for solutionsubcutaneous3.5 mg/mL

Prescription Generics

false

International Brands

Synribo

Synonyms

( )-homoharringtonine (2’R,3S,4S,5R)-( )-homoharringtonine

Manufacturers

Cephalon, Inc.

CAS number

26833-87-4

UNII

6FG8041S5B

State

solid

Affected organisms

Humans and other mammals

Indication of Omacetaxine mepesuccinate

Used in patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.

Toxicity of Omacetaxine mepesuccinate

The most severe adverse effects after homoharringtonine administration are myelosuppression, bleeding, hyperglycemia, and fetal harm.

RX24 Drugs Disclaimer: consult your healthcare provider before buying a Omacetaxine mepesuccinate on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Omacetaxine mepesuccinate now!